Topic
moderna
3 stories related to this topic, newest first.
cnet.comscience5 hrs ago
FDA Advisory Panel Backs Moderna mRNA Flu Vaccine for Older Adults but Final Approval Remains Pending
VRBPAC voted unanimously on June 18 that benefits outweigh risks for adults ages 50-64 and 65+. The final FDA decision on licensure remains pending.
abcnews.go.comscience3 days agoUpdated
FDA Panel Endorses Moderna mRNA Flu Vaccine for Ages 50 and Up but Requires Further Trial for Ages 65 and Older
An advisory committee voted unanimously Thursday to support licensure of the shot for adults aged 50–64 via the traditional pathway and for adults 65 and older via the accelerated pathway. The FDA is expected to decide by August 5.
Substrate placeholder — needs reviewscience61 days ago
European Commission Grants Marketing Authorization for Moderna's MCOMBRIAX Vaccine
Moderna has received marketing authorization from the European Commission for MCOMBRIAX, its mRNA combination vaccine against influenza and COVID-19. This enables distribution in European markets. The vaccine targets respiratory viruses with combined protection.
FI